Sotera Health (SHC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Sotera Health Company (SHC) reported $280.05 million in revenue for the quarter ended March 2026, representing a year-over-year increase of 10%. EPS of $0.18 for the same period compares to $0.14 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $271.98 million, representing a surprise of +2.97%. The company delivered an EPS surprise of +3.87%, with the consensus EPS estimate being $0.17.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Sotera Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Net Revenues- Sterigenics: $186.14 million compared to the $183.41 million average estimate based on two analysts. The reported number represents a change of +9.7% year over year. Net Revenues- Nelson Labs: $51.9 million compared to the $51.84 million average estimate based on two analysts. The reported number represents a change of -0.7% year over year. Net Revenues- Nordion: $42.01 million versus the two-analyst average estimate of $38.17 million. The reported number represents a year-over-year change of +29%.
View all Key Company Metrics for Sotera Health here>>>
Shares of Sotera Health have returned +3.5% over the past month versus the Zacks S&P 500 composite's +9.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Sotera Health Company (SHC) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
View Comments
Google